{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:18:34Z","timestamp":1790889514474,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002001","name":"Health Services and Delivery Research Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012775","name":"Royal Melbourne Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["279062"],"award-info":[{"award-number":["279062"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Epilepsia Open"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To study the effectiveness and tolerability of antiepileptic drugs (AEDs) commonly used in juvenile myoclonic epilepsy (JME).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>People with JME were identified from a large database of individuals with epilepsy, which includes detailed retrospective information on AED use. We assessed secular changes in AED use and calculated rates of response (12\u2010month seizure freedom) and adverse drug reactions (ADRs) for the five most common AEDs. Retention was modeled with a Cox proportional hazards model. We compared valproate use between males and females.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We included 305 people with 688 AED trials of valproate, lamotrigine, levetiracetam, carbamazepine, and topiramate. Valproate and carbamazepine were most often prescribed as the first AED. The response rate to valproate was highest among the five AEDs (42.7%), and significantly higher than response rates for lamotrigine, carbamazepine, and topiramate; the difference to the response rate to levetiracetam (37.1%) was not significant. The rates of ADRs were highest for topiramate (45.5%) and valproate (37.5%). Commonest ADRs included weight change, lethargy, and tremor. In the Cox proportional hazards model, later start year (1.10 [1.08\u20101.13],<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001) and female sex (1.41 [1.07\u20101.85],<jats:italic>P<\/jats:italic>\u00a0=\u00a00.02) were associated with shorter trial duration. Valproate was associated with the longest treatment duration; trials with carbamazepine and topiramate were significantly shorter (HR [CI]: 3.29 [2.15\u20105.02],<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001 and 1.93 [1.31\u20102.86],<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001). The relative frequency of valproate trials shows a decreasing trend since 2003 while there is an increasing trend for levetiracetam. Fewer females than males received valproate (76.2% vs 92.6%,<jats:italic>P<\/jats:italic>\u00a0=\u00a00.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Significance<\/jats:title><jats:p>In people with JME, valproate is an effective AED; levetiracetam emerged as an alternative. Valproate is now contraindicated in women of childbearing potential without special precautions. With appropriate selection and safeguards in place, valproate should remain available as a therapy, including as an alternative for women of childbearing potential whose seizures are resistant to other treatments.<\/jats:p><\/jats:sec>","DOI":"10.1002\/epi4.12349","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T07:10:31Z","timestamp":1561533031000},"page":"420-430","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy"],"prefix":"10.1002","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-0029","authenticated-orcid":false,"given":"Katri","family":"Silvennoinen","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London UK"},{"name":"Chalfont Centre for Epilepsy Chalfont St. Peter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"de Lange","sequence":"additional","affiliation":[{"name":"Luxembourg Centre for Systems Biomedicine University of Luxembourg Belvaux Luxembourg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Zagaglia","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London UK"},{"name":"Chalfont Centre for Epilepsy Chalfont St. Peter UK"},{"name":"Department of Experimental and Clinical Medicine Polytechnic University of Marche Ancona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Balestrini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London UK"},{"name":"Chalfont Centre for Epilepsy Chalfont St. Peter UK"},{"name":"Department of Experimental and Clinical Medicine Polytechnic University of Marche Ancona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganna","family":"Androsova","sequence":"additional","affiliation":[{"name":"Luxembourg Centre for Systems Biomedicine University of Luxembourg Belvaux Luxembourg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel","family":"Wassenaar","sequence":"additional","affiliation":[{"name":"Stichting Epilepsie Instellingen Nederland (SEIN) Heemstede The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauls","family":"Auce","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine University of Liverpool Liverpool UK"},{"name":"The Walton Centre NHS Foundation Trust Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreja","family":"Avbersek","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Becker","sequence":"additional","affiliation":[{"name":"Hertie Institute for Clinical Brain Research University of T\u00fcbingen T\u00fcbingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Berghuis","sequence":"additional","affiliation":[{"name":"Stichting Epilepsie Instellingen Nederland (SEIN) Heemstede The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Campbell","sequence":"additional","affiliation":[{"name":"Belfast Health and Social Care Trust Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Coppola","sequence":"additional","affiliation":[{"name":"Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health University of Genoa Genoa Italy"},{"name":"Department of Neuroscience, Reproductive and Odontostomatological Sciences Federico II University Naples Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Francis","sequence":"additional","affiliation":[{"name":"Department of Biostatistics University of Liverpool Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wolking","sequence":"additional","affiliation":[{"name":"Hertie Institute for Clinical Brain Research University of T\u00fcbingen T\u00fcbingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9802-0506","authenticated-orcid":false,"given":"Gianpiero L.","family":"Cavalleri","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Therapeutics Royal College of Surgeons in Ireland Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Craig","sequence":"additional","affiliation":[{"name":"Belfast Health and Social Care Trust Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3953-9842","authenticated-orcid":false,"given":"Norman","family":"Delanty","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Therapeutics Royal College of Surgeons in Ireland Dublin Ireland"},{"name":"Department of Neurology Beaumont Hospital Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Division of Brain Sciences Imperial College London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby P. C.","family":"Koeleman","sequence":"additional","affiliation":[{"name":"Department of Genetics University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram S.","family":"Kunz","sequence":"additional","affiliation":[{"name":"Department of Epileptology University of Bonn Bonn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Lerche","sequence":"additional","affiliation":[{"name":"Hertie Institute for Clinical Brain Research University of T\u00fcbingen T\u00fcbingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G.","family":"Marson","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine University of Liverpool Liverpool UK"},{"name":"The Walton Centre NHS Foundation Trust Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Departments of Neuroscience and Neurology, Central Clinical School Monash University, The Alfred Hospital Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josemir W.","family":"Sander","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London UK"},{"name":"Chalfont Centre for Epilepsy Chalfont St. Peter UK"},{"name":"Stichting Epilepsie Instellingen Nederland (SEIN) Heemstede The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J.","family":"Sills","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine University of Liverpool Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6065-1476","authenticated-orcid":false,"given":"Pasquale","family":"Striano","sequence":"additional","affiliation":[{"name":"Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health University of Genoa Genoa Italy"},{"name":"Pediatric Neurology and Muscular Diseases Unit IRCCS Istituto G. Gaslini Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Zara","sequence":"additional","affiliation":[{"name":"Laboratory of Neurogenetics and Neuroscience IRCCS Istituto G. Gaslini Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Job","family":"van der Palen","sequence":"additional","affiliation":[{"name":"University of Twente Enschede The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9938-7126","authenticated-orcid":false,"given":"Roland","family":"Krause","sequence":"additional","affiliation":[{"name":"Luxembourg Centre for Systems Biomedicine University of Luxembourg Belvaux Luxembourg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-5319","authenticated-orcid":false,"given":"Chantal","family":"Depondt","sequence":"additional","affiliation":[{"name":"Department of Neurology H\u00f4pital Erasme, Universit\u00e9 Libre de Bruxelles Brussels Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1511-5893","authenticated-orcid":false,"given":"Sanjay M.","family":"Sisodiya","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London UK"},{"name":"Chalfont Centre for Epilepsy Chalfont St. Peter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the EpiPGX Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2012.06.024"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2012.11.051"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2013.01.001"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.70.2.240"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2014.03.017"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.10.004"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2013.06.012"},{"key":"e_1_2_9_9_1","unstructured":"European Medicines Agency.New measures to avoid valproate exposure in pregnancy endorsed. EMA\/145600\/2018. 2018.http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2018\/03\/WC500246391.pdf. Accessed December 19 2018."},{"key":"e_1_2_9_10_1","first-page":"75","article-title":"The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies","volume":"75","author":"Nicolson A","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2016.07.011"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2015.11.012"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.8.1100"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60461-9"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000437303.36064.f8"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl048"},{"key":"e_1_2_9_17_1","unstructured":"International League Against Epilepsy. EpilepsyDiagnosis.org:Juvenile myoclonic epilepsy.https:\/\/www.epilepsydiagnosis.org\/syndrome\/jme-overview.html. Accessed December 19 2018."},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02397.x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2016.04.047"},{"key":"e_1_2_9_20_1","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2015"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13871"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(00)00496-2"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03355.x"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.3949"},{"key":"e_1_2_9_25_1","unstructured":"National Institute for Health and Care Excellence.Epilepsies: diagnosis and management. Nice Clinical Guidelines 2012; CG137.https:\/\/www.nice.org.uk\/guidance\/cg137. Accessed March 31 2018."},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182563b19"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(96)01007-8"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.8.1106"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2009.02.016"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000177"},{"key":"e_1_2_9_31_1","doi-asserted-by":"crossref","unstructured":"LiuJ WangLN WangYP.Topiramate monotherapy for juvenile myoclonic epilepsy. Cochrane Database of Systematic Reviews.https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010008.pub3\/full. Accessed December 19 2018.","DOI":"10.1002\/14651858.CD010008.pub3"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.03.013"},{"key":"e_1_2_9_33_1","doi-asserted-by":"crossref","unstructured":"NevittSJ SudellM WestonJ Tudur SmithC MarsonAG.Antiepileptic drug monotherapy for epilepsy: a network meta\u2010analysis of individual participant data. Cochrane Database of Systematic Reviews.https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011412.pub2\/full. Accessed December 19 2018.","DOI":"10.1002\/14651858.CD011412.pub2"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2016.1179113"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2013.03.026"},{"key":"e_1_2_9_36_1","volume-title":"Joint formulary committee","author":"Joint Formulary Committee"},{"key":"e_1_2_9_37_1","unstructured":"Medicines and Healthcare Products Regulatory Agency.Safety update. Volume 7 issue 4;2013."},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.01.019"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13604"}],"container-title":["Epilepsia Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fepi4.12349","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/epi4.12349","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/epi4.12349","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/epi4.12349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T07:00:16Z","timestamp":1721458816000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/epi4.12349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1002\/epi4.12349"],"URL":"https:\/\/doi.org\/10.1002\/epi4.12349","archive":["Portico"],"relation":{},"ISSN":["2470-9239","2470-9239"],"issn-type":[{"value":"2470-9239","type":"print"},{"value":"2470-9239","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"2019-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}